Free Trial
→ No. You’re not imagining it… (From Porter & Company) (Ad)tc pixel Free HKPD Stock Alerts

Hong Kong Pharma Digital Technology (HKPD) Competitors

Hong Kong Pharma Digital Technology logo
$0.53 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$0.55 +0.02 (+3.96%)
As of 05/22/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

HKPD vs. EPSM, MWYN, UUU, SCNX, and COSM

Should you buy Hong Kong Pharma Digital Technology stock or one of its competitors? MarketBeat compares Hong Kong Pharma Digital Technology with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Hong Kong Pharma Digital Technology include Epsium Enterprise (EPSM), Marwynn (MWYN), Universal Security Instruments (UUU), Scienture (SCNX), and Cosmos Health (COSM). These companies are all part of the "wholesale" industry.

How does Hong Kong Pharma Digital Technology compare to Epsium Enterprise?

Epsium Enterprise (NASDAQ:EPSM) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap wholesale companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Hong Kong Pharma Digital Technology has higher revenue and earnings than Epsium Enterprise.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Epsium Enterprise$5.12M3.49-$1.50MN/AN/A
Hong Kong Pharma Digital Technology$20.31M0.29-$30KN/AN/A

In the previous week, Epsium Enterprise and Epsium Enterprise both had 1 articles in the media. Epsium Enterprise's average media sentiment score of 0.00 equaled Hong Kong Pharma Digital Technology'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Epsium Enterprise
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Hong Kong Pharma Digital Technology
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Epsium Enterprise
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Epsium Enterprise has a beta of 1.95, indicating that its share price is 95% more volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.64, indicating that its share price is 164% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
Epsium EnterpriseN/A N/A N/A
Hong Kong Pharma Digital Technology N/A N/A N/A

Summary

Hong Kong Pharma Digital Technology beats Epsium Enterprise on 3 of the 4 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Marwynn?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Marwynn (NASDAQ:MWYN) are both small-cap wholesale companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations.

Hong Kong Pharma Digital Technology has a beta of 2.64, suggesting that its stock price is 164% more volatile than the broader market. Comparatively, Marwynn has a beta of 3.51, suggesting that its stock price is 251% more volatile than the broader market.

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Marwynn's net margin of -121.92%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Marwynn's return on equity.

Company Net Margins Return on Equity Return on Assets
Hong Kong Pharma Digital TechnologyN/A N/A N/A
Marwynn -121.92%-244.66%-72.88%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Marwynn
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Hong Kong Pharma Digital Technology had 1 more articles in the media than Marwynn. MarketBeat recorded 1 mentions for Hong Kong Pharma Digital Technology and 0 mentions for Marwynn. Hong Kong Pharma Digital Technology's average media sentiment score of 0.00 equaled Marwynn'saverage media sentiment score.

Company Overall Sentiment
Hong Kong Pharma Digital Technology Neutral
Marwynn Neutral

Hong Kong Pharma Digital Technology has higher revenue and earnings than Marwynn.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hong Kong Pharma Digital Technology$20.31M0.29-$30KN/AN/A
Marwynn$11.10M1.60-$4.40M-$0.50N/A

Summary

Hong Kong Pharma Digital Technology beats Marwynn on 6 of the 8 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Universal Security Instruments?

Universal Security Instruments (NYSE:UUU) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap wholesale companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, media sentiment, risk, analyst recommendations, valuation and institutional ownership.

In the previous week, Universal Security Instruments had 2 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 3 mentions for Universal Security Instruments and 1 mentions for Hong Kong Pharma Digital Technology. Universal Security Instruments' average media sentiment score of 1.71 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that Universal Security Instruments is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Universal Security Instruments
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Hong Kong Pharma Digital Technology
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Universal Security Instruments has a beta of -0.08, meaning that its stock price is 108% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.64, meaning that its stock price is 164% more volatile than the broader market.

Hong Kong Pharma Digital Technology has higher revenue and earnings than Universal Security Instruments.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Universal Security Instruments$10.83M1.88-$400K-$0.08N/A
Hong Kong Pharma Digital Technology$20.31M0.29-$30KN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Universal Security Instruments
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Universal Security Instruments' net margin of -5.77%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Universal Security Instruments' return on equity.

Company Net Margins Return on Equity Return on Assets
Universal Security Instruments-5.77% -27.30% -12.88%
Hong Kong Pharma Digital Technology N/A N/A N/A

Summary

Hong Kong Pharma Digital Technology beats Universal Security Instruments on 7 of the 10 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Scienture?

Scienture (NASDAQ:SCNX) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap wholesale companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings and valuation.

In the previous week, Hong Kong Pharma Digital Technology had 1 more articles in the media than Scienture. MarketBeat recorded 1 mentions for Hong Kong Pharma Digital Technology and 0 mentions for Scienture. Scienture's average media sentiment score of 0.00 equaled Hong Kong Pharma Digital Technology'saverage media sentiment score.

Company Overall Sentiment
Scienture Neutral
Hong Kong Pharma Digital Technology Neutral

Scienture currently has a consensus price target of $1.50, indicating a potential upside of 273.13%. Given Scienture's stronger consensus rating and higher probable upside, analysts clearly believe Scienture is more favorable than Hong Kong Pharma Digital Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Scienture
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

5.7% of Scienture shares are owned by institutional investors. 21.4% of Scienture shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Hong Kong Pharma Digital Technology has higher revenue and earnings than Scienture.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scienture$430K37.98-$41.51M-$2.51N/A
Hong Kong Pharma Digital Technology$20.31M0.29-$30KN/AN/A

Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Scienture's return on equity.

Company Net Margins Return on Equity Return on Assets
ScientureN/A -56.28% -44.76%
Hong Kong Pharma Digital Technology N/A N/A N/A

Scienture has a beta of 3.32, suggesting that its stock price is 232% more volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.64, suggesting that its stock price is 164% more volatile than the broader market.

Summary

Scienture beats Hong Kong Pharma Digital Technology on 7 of the 12 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Cosmos Health?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Cosmos Health (NASDAQ:COSM) are both small-cap wholesale companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.

Hong Kong Pharma Digital Technology has a beta of 2.64, suggesting that its share price is 164% more volatile than the broader market. Comparatively, Cosmos Health has a beta of 5, suggesting that its share price is 400% more volatile than the broader market.

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Cosmos Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hong Kong Pharma Digital Technology$20.31M0.29-$30KN/AN/A
Cosmos Health$65.27M0.21-$19.15M-$0.64N/A

12.6% of Cosmos Health shares are owned by institutional investors. 25.1% of Cosmos Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Cosmos Health had 3 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 4 mentions for Cosmos Health and 1 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 0.00 beat Cosmos Health's score of -0.36 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hong Kong Pharma Digital Technology
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cosmos Health
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Cosmos Health's net margin of -30.41%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Cosmos Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hong Kong Pharma Digital TechnologyN/A N/A N/A
Cosmos Health -30.41%-52.85%-17.87%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Cosmos Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Hong Kong Pharma Digital Technology beats Cosmos Health on 6 of the 11 factors compared between the two stocks.

Get Hong Kong Pharma Digital Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for HKPD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HKPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HKPD vs. The Competition

Export
MetricHong Kong Pharma Digital TechnologyWholesale – Drugs & Drug Proprietaries IndustryRetail SectorNASDAQ Exchange
Market Cap$5.83M$5.83M$27.26B$12.34B
Dividend YieldN/AN/A178.40%5.28%
P/E RatioN/AN/A19.8125.66
Price / Sales0.290.294.1186.31
Price / CashN/AN/A14.9556.67
Price / BookN/AN/A5.197.14
Net Income-$30K-$30K$957.86M$335.98M
7 Day Performance-0.75%-0.75%2.52%4.11%
1 Month Performance-20.54%-20.54%-0.78%2.52%
1 Year Performance-52.25%-52.25%1.97%35.04%

Hong Kong Pharma Digital Technology Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HKPD
Hong Kong Pharma Digital Technology
N/A$0.53
flat		N/A-52.3%$5.83M$20.31MN/A19
EPSM
Epsium Enterprise
0.5864 of 5 stars		$1.37
+2.2%		N/A-90.6%$18.41M$5.12MN/A13
MWYN
Marwynn
0.2308 of 5 stars		$0.87
+5.3%		N/A-90.1%$17.57M$11.10MN/A27
UUU
Universal Security Instruments
N/A$6.03
-2.9%		N/A+216.3%$16.88M$10.83MN/A10
SCNX
Scienture
2.1578 of 5 stars		$0.40
-1.9%		$1.50
+272.2%		-54.1%$16.37M$431.61KN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:HKPD) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
The S-1 just dropped. 22 days left.
The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...
Behind the Markets | Sponsoredtc pixel
My crisis of conscience
Emmet Savage - named in Irish America's Wall Street 50 as one of the most successful investors in the world - ...
Porter & Company | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
Trump Admin to Pump $1 Billion into this “Off-the-Radar” AI Stock
The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...
InvestorPlace | Sponsoredtc pixel
Opportunity Forming in a U.S. Supply-Chain Weak Spot?
America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources rema...
i2i Marketing Group, LLC | Sponsoredtc pixel